Maximise the value and impact of your products
We partner with biopharma, CROs, CCOs and health systems to unlock medicines access to patients across Europe.
Discover our services
We support trial continuity and patient logistics across Europe – with proven delivery models in complex markets requiring precision, multilingual engagement and regulatory fluency.
Clinical trials
We support trial continuity and patient logistics across Europe – with proven delivery models in complex markets requiring precision, multilingual engagement and regulatory fluency.
Early access programmes and market access
We enable safe, compliant access to therapies across Europe – from unlicensed medicine delivery to early access programmes with multilingual support.
Aseptic compounding
We prepare and deliver complex, high-value therapies with hospital-grade precision – including oncology and specialty medicines administered at home, supported by regulatory-compliant workflows.
Supply chain and logistics
We streamline the referral-to-care process – combining trusted clinician relationships, multilingual support, and industry-leading dispense and delivery to ensure patients start treatment safely and quickly.
Treatment delivery and ongoing engagement
We deliver therapy safely through clinician-led medication, track adherence in real time, and keep patients engaged through digital tools, multilingual clinical teams, and cross-border logistics.
Evidence generation
We capture real-world data, patient-reported outcomes, and adherence trends – generating evidence that meets both global standards and local regulatory expectations across Europe. We also provide comprehensive pharmacovigilance solutions at a country-by-country level.
Partner with us to unlock access to European patients
Scalability
Expertise
Bespoke solutions
Our impact
With 30+ years of in-market expertise, Sciensus has superior access to patients – our distribution and clinical care infrastructure enables us to help you get the right drug to the right patients faster and then we can provide the personalised support to drive adherence, reduce drop-off and collect real world data.
0
patient interactions
0
patients treated annually
0 +
regimens supported across 125 different medicines
0
relationships with hospitals, clinics and pharmacies in Europe
Get in touch
Thank you for your interest in Sciensus. Whether you’re seeking information, partnership opportunities, or want to refer a patient, our dedicated team is here to assist you. Please fill out the form on the right, and one of our multi-lingual representatives will get in touch with you promptly.
Powered by insight
Stay up to date with the news, find out more about our latest developments and learn from experts across Sciensus.
Thought Leadership
A strategic framework for global access and personalised care
Rare diseases, while individually uncommon, collectively impact over 300 million people worldwide, representing approximately 3.5–5.9% of the global population. Despite…
Blogs
Breaking into Europe – challenges and strategies
The Sciensus team recently held a speaking session on Breaking into Europe at the World Orphan Drug Congress (WODC) in…
Blogs
Driving reimbursement success in Europe with real-world data
Andrew Cummins, Vice President Business Development, and Mathieu Loiseau, Director of Rare Clinical Services, spoke at the recent World Orphan…